Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
A palpable chest wall mass in a 4-year-old boyJakob M Domm, Joanne M Langley
Cureus|March 3, 2022
Treatment-Resistant Wide-Complex Tachycardia in a Three-Year-Old GirlJakob M Domm, Kirstin Weerdenburg, Renée Kinden, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2019
AAV-Mediated Gene Delivery to the LungLaura P van Lieshout, Jakob M Domm, Sarah K Wootton
Molecular Genetics and Metabolism|August 3, 2021
Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editingJakob M Domm, Sarah K Wootton, Jeffrey A Medin, et al.
Molecular Therapy. Methods & Clinical Development|July 25, 2018
A Novel Triple-Mutant AAV6 Capsid Induces Rapid and Potent Transgene Expression in the Muscle and Respiratory Tract of MiceLaura P van Lieshout, Jakob M Domm, Tara N Rindler, et al.
Viruses|November 20, 2019
The U3 and Env Proteins of Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus Both Contribute to Tissue TropismMaría C Rosales Gerpe, Laura P van Lieshout, Jakob M Domm, et al.
Human Gene Therapy|February 1, 2020
Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene DeliveryMaría C Rosales Gerpe, Laura P van Lieshout, Jakob M Domm, et al.
Nature Communications|August 9, 2020
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiencyMartin H Kang, Laura P van Lieshout, Liqun Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2023
A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiencySylvia P Thomas, Jakob M Domm, Jacob P van Vloten, et al.
Pageof 1